Peripheral Helper T-cells in Common Variable ImmunoDeficiency

Recruiting N/A Interventional Study
Common Variable Immunodeficiency
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
60 (estimated)
Sponsor
University Hospital, Bordeaux · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The aim is to determine whether whether Tph could support non-infectious complications through providing help to pathological B-cells.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female; * Age ≥ 18 years; * Standard criteria will be applied to diagnose CVID, specifically requiring: 1) low serum IgG level \<5 g/L, combined with low IgM- and/or IgA-isotype concentrations \<0.4 g/L or \<0.7 g/L, respectively; 2) poor antibody responses to immuniza…
Contacts

Jean-François VIALLARD, Prof

(0)5.57.65.64.83

jean-françois.viallard@chu-bordeaux.fr

CONTACT

Carine LOPEZ

(0)5.24.54.91.32

carine.lopez@chu-bordeaux.fr

CONTACT